Public Policy
PSAM focuses its advocacy efforts on state legislation and regulation that impact the field of addiction medicine and people with SUD in Pennsylvannia.
PSAM Public Policy Committee (PPBC)
Dear friends,
For those that I have not met yet, I am the current Chair of the PSAM Public Policy Committee (PPC). We decided to put together a section in the PSAM Review to keep our members and the addiction community abreast of our work to advocate for us and our patients. In this first article, I’ll introduce you to our committee and our recent efforts. Even more importantly, I hope to convince you to get involved in some way!
The PPC is made up of about a dozen PSAM member volunteers across the state. We advocate for PSAM members and our patients to the state government as well as county and local governments. ASAM takes primary responsibility for advocating on a federal level, though our PPC members might support those on an ad-hoc basis. We are one of several states identified as “Intensive Partnership” chapters working with ASAM closely on advocacy issues.
We have identified three key areas for advocacy that we have focused on for the last year:
1. Increasing access to addiction treatment services, including providers and specific treatments (medication, therapy, etc.)
2. Improving implementation of evidence-based harm reduction strategies
3. Ensuring that scientific evidence is considered when creating new legislation affecting our patients and our field
We have worked on several issues over the last year in these areas, which have involved discussions with policymakers and sometimes issuing letters of support or opposition.
We issued a letter of support for PA House Bill 1974, which would create a state grant program for funding contingency management for stimulant use disorders. This bill passed in committee, and we are hoping that it will be voted on in the house this year. We have delivered letters opposing efforts that threatened to reduce access to harm reduction services, including Philadelphia Council Bill 24066 and PA Senate Bill 347.
We have been partnering with policymakers on both sides of the political aisle to create a regulatory framework for kratom, including issuing a letter supporting PA House Bill 2058 and Senate Bill 899. We are collaborating with legislators now to pass a comprehensive regulatory bill.
We are acutely aware of the rapidly growing problems caused by the expansion of easily accessed forms of gambling, especially online through sports betting and games of chances like mobile game slots. House Resolution 60 was passed in May 2025, directing the Joint State Government Commission to conduct a study of the harms of sports and interactive gaming in PA. We have been in communication with the commission as they prepare their report, and wrote and co-signed a position statement with the Pennsylvania Psychiatric Society about state interventions to reduce the harms from online gambling in PA. We will continue to advocate in this area for some protections to be put in place to stem the tide of what is becoming an epidemic of gambling harms and addiction in PA.
Along with continuing our advocacy around these items, we are always keeping an eye out for upcoming legislative needs. We are in the process now of creating a PA-specific position statement on harm reduction measures that we hope to see included if our state ever passes legislation legalizing recreational cannabis. The position statement will likely be finalized by the time you read this.
We are creating a new way to have PSAM members become involved in our advocacy efforts without committing to PPC membership. There are often bills that need to be discussed with specific legislators, and these messages are much more effective when they come from one of their constituents. If you sign up to be involved, our committee will reach out to you when something concerns your specific legislator. We’ll discuss how to approach them and support you in doing so. You can sign up to help via this link:
https://forms.office.com/r/CejmrnF5as
In general, I would encourage everyone to find out who your state reps are and at least reach out to introduce yourselves. If you want to become more involved in federal advocacy topics, I suggest signing up for ASAM’s 2026 advocacy conference. This year the trainings will be virtual and we will be meeting with legislators in their home offices, which should be much more accessible and hopefully give them more time to meet with us.
Advocacy has always been a part of addiction medicine. Regardless of your level of involvement in our systemic advocacy work, thank you for your continued care of patients and support for PSAM. Our committee looks forward to continuing to serve you, our patients, and our field.
Robert Tessier, MD, MPH
PSAM Public Policy Committee, Chair
Shape the Future of Kratom Policy in PA
Pennsylvania is poised to pass critical legislation that would heavily regulate kratom products, while also minimizing its harm.
Pennsylvania is poised to pass critical legislation which would heavily regulate kratom products, while also minimizing it harm...
Mitigating Gambling Harm in Pennsylvania
The Pennsylvania Psychiatric Society (PaPS), a district branch of the American Psychiatric Association (APA), represents more than 1300 physicians practicing the medical specialty of psychiatry in Pennsylvania...
Mitigation from Recreational Cannabis in Pennsylvania
We have created this position statement to emphasize the need to include safety measures in recreational cannabis legislation.
As of 2024, 39 states and DC have enacted medical cannabis laws and 24 states and DC have enacted recreational cannabis laws. Currently, over half of US residents live in localities (52.8%) where recreational cannabis is legal...